Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRPR | P30550 | 3/20 | 0.39 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.35 |
| ▸ | OPRD1 | P41143 | 4/20 | 0.35 |
| ▸ | OPRM1 | P35372 | 3/20 | 0.35 |
| ▸ | GLP1R | P43220 | 2/20 | 0.35 |
| ▸ | SCTR | P47872 | 1/20 | 0.35 |
| ▸ | DPP4 | P27487 | 1/20 | 0.35 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.35 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.35 |
| ▸ | F2 | P00734 | 3/20 | 0.34 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29599778 | 0.88 | CALCR (0.43) | C5AR1GLP1RSCTRF2 | |
| SCHEMBL29856045 | 0.86 | BACE1 (0.44) | GRPRGLP1RSCTRF2 | |
| SCHEMBL30455944 | 0.86 | PTGS1 (0.39) | GRPRDPP4DPP8DPP9 | |
| SCHEMBL29593326 | 0.85 | PRMT1 (0.41) | GRPRC5AR1OPRD1OPRM1GLP1R | |
| SCHEMBL30646307 | 0.84 | OPRD1 (0.52) | OPRD1OPRM1OPRK1 | |
| SCHEMBL29398797 | 0.84 | OPRD1 (0.38) | OPRD1OPRM1OPRK1 | |
| SCHEMBL29590467 | 0.84 | GRPR (0.39) | GRPROPRD1OPRM1GLP1RSCTR | |
| SCHEMBL30843968 | 0.83 | NPY4R (0.44) | C5AR1OPRD1OPRM1 | |
| SCHEMBL31544067 | 0.83 | OPRM1 (0.47) | OPRD1OPRM1GLP1RSCTRF2 | |
| SCHEMBL2780884 | 0.82 | DPP4 (0.39) | DPP4DPP8DPP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4613259-A1 | PHARMACEUTICAL, DERMATOLOGICAL OR COSMETIC COMPOUNDS AND COMPOSITIONS FOR REDUCING MELANIN SYNTHESIS, STIMULATING TYPE I COLLAGEN PRODUCTION, SKIN DEPIGMENTATION AND/OR PROMOTING A SKIN ANTI-AGING EFFECT IN AN INDIVIDUAL OR ANIMAL, USES AND METHODS | Chemyunion Ltda (BR) | 2025-09-10 | — | — | EP | disclosed |